You are here :
Home
Healthcare Market Research Reports
PRODUCT TITLE | PUBLISHED | |
---|---|---|
Recombinant Peptides Recombinant Peptides and Recombinant Non-Glycosylated Proteins and |
Upcoming | |
Prefilled Prefilled and Fillable adds up to total Injectables Drug... |
Upcoming | |
Fillable Fillable and Prefilled adds up to total Injectables Drug... |
Upcoming | |
Standardized Auto Injectors Standardized Auto Injectors and Customized Auto Injectors adds up to total |
Upcoming | |
Customized Auto Injectors Customized Auto Injectors and Standardized Auto Injectors adds up to total |
Upcoming | |
Center Use Hemodialysis Center Use Hemodialysis and Home Hemodialysis, |
Upcoming | |
Home Hemodialysis Home Hemodialysis and Center Use Hemodialysis, |
Upcoming | |
Continuous Cycling Peritoneal Dialysis (CCPD) Continuous Cycling Peritoneal Dialysis (CCPD) and Center Use Hemodialysis, |
Upcoming | |
Continuous Ambulatory Peritoneal Dialysis (CAPD) Continuous Ambulatory Peritoneal Dialysis (CAPD) and Center Use Hemodialysis, |
Upcoming | |
Intermittent PD (IPD) Intermittent PD (IPD) and Center Use Hemodialysis, Home... |
Upcoming | |
PD Plus Therapy PD Plus Therapy and Center Use Hemodialysis, Home... |
Upcoming | |
Peritoneal Dialysis The “Global Peritoneal dialysis Market”, mainly driven by increase in the number of ESRD patient population, was pegged at $ 9.1 billion in 2012 and expected to be $ 16.4 billion by 2020, growing at a CAGR of 7.6%. The market has 2 main segments such as Peritoneal dialysis product and Peritoneal services. The main companies operating in Peritoneal dialysis market, extensively covered in this report are Baxter International, Inc. (U.S.) and Fresenius Medical CareAG & Co. KGaA (Germany), etc. |
Upcoming | |
Blood glucose monitors Blood glucose monitors and Blood pressure monitors, |
Upcoming | |
Blood pressure monitors The “Global Blood pressure monitors Market”, mainly driven by increase chronically ill population, was pegged at $ 1.3 billion in 2012 and expected to be $ 2 billion by 2020, growing at a CAGR of 5.3%. The market has 2 segments such as Aneroid and Digital monitors. The key players are Omron Healthcare (Japan) (which holds around 50% share); the other major players are Microlife (Switzerland) and A&D Medical (U.S.). |
Upcoming | |
Blood cholesterol monitors Blood cholesterol monitors and Blood glucose monitors, |
Upcoming | |
Blood gas monitors The global Blood gas and electrolyte analyzers market is driven by inadequacy of alternate techniques. The market value was estimated $434 million in 2012 and is expected to reach $570 million by 2018, at a CAGR of 4.6%. The market is segmented into monitors such as Portable and Desktop. The key players of the market covered in this report are Roche, Siemens, Abbott and Bayer Healthcare. |
Upcoming | |
Low acuity Low acuity and Mid acuity and High acuity adds up to total |
Upcoming | |
Mid acuity Mid acuity and Low acuity and High acuity adds up to total |
Upcoming | |
High acuity High acuity and Low acuity and Mid acuity adds up to total |
Upcoming | |
Defibrillators The Global Defibrillators Market was pegged at $9.9 billion in 2013 and expected to be $13.4 billion by 2018, growing at a CAGR of 6.2%. The Global Defibrillators Market can be segmented by Submarkets,Geographies, Companies and MacroIndicators. Deep dive analysis of the key players of this market have been considered in this report. |
Upcoming |
Healthcare